Gibson Dunn & Crutcher advised Merck on the transaction and Wilson Sonsini Goodrich & Rosati advised LaNova Medicines. Merck (NYSE: MRK), known as MSD outside of...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell is advising Nippon Paint Holdings Co., Ltd. on the transaction, Gibson Dunn & Crutcher is advising Lone Star Funds and Jamieson Corporate...
You must be a Standard 1 Year member to access this content.
Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is representing Bora Pharmaceuticals in its acquisition of Upsher-Smith Laboratories. Bora Pharmaceuticals Co., Ltd. announced the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Merck on the agreement. Daiichi Sankyo (TSE: 4568) and Merck (known as MSD outside of the United States and...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Patterson-UTI Energy, Inc., while Kirkland & Ellis is advising Blackstone Energy Partners in the transaction. Patterson-UTI Energy, Inc. (NASDAQ:PTEN)...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis LLP is serving as legal advisor to NexTier, while Gibson, Dunn & Crutcher LLP is serving as legal advisor to Patterson-UTI. Patterson-UTI Energy,...
You must be a Standard 1 Year member to access this content.
